8-K: Oscar Health Revises 2025 Outlook Downward Amid Higher Marketplace Risk Scores

Oscar Health announced preliminary Q2 2025 losses and revised its full-year 2025 financial guidance, citing higher-than-expected ACA Marketplace risk scores and elevated member utilization.

Summary

• Preliminary Q2 2025 loss from operations is approximately $230 million.
• Preliminary Q2 2025 net loss is approximately $228 million.
• Revised full-year 2025 Total Revenue is now anticipated to be $12.0 billion to $12.2 billion.
• The revised full-year 2025 Medical Loss Ratio (MLR) is expected to be 86.0% to 87.0%.
• The revised full-year 2025 SG&A Expense Ratio is projected at 17.1% to 17.6%.
• The revised full-year 2025 Loss from Operations is now estimated to be ($300 million) to ($200 million).
• An Adjusted EBITDA loss of approximately $120 million less than the Loss from Operations is expected for the full year 2025.
• The preannouncement is driven by a review of 2Q Risk Adjustment Reports from Wakely, an independent actuarial firm, which indicates that overall ACA Marketplace risk scores have increased by more than prior estimates.
• Utilization by members remained elevated in Q2 2025, although cost trends moderated compared to Q1 2025.
• The company plans to resubmit rate filings for 2026 in states covering approximately 98% of current membership to reflect the higher market risk scores in the ACA Marketplace.
• 2024 risk adjustment results were approximately $23 million favorable to the company's accruals as of Q1 2025.

Sentiment

Score: 3

Explanation: The revised financial guidance indicates a significant deterioration in the company's outlook for 2025, with increased projected losses and a higher medical loss ratio. While management expresses confidence in navigating dynamic markets and taking pricing actions for 2026, the immediate financial impact is negative.

Positives

• 2024 risk adjustment results were approximately $23 million favorable to accruals as of Q1 2025.
• Cost trends moderated in Q2 2025 compared to Q1 2025, despite elevated utilization.
• Management is taking appropriate pricing actions for 2026 to reflect higher acuity in the individual market.

Negatives

• Preliminary Q2 2025 loss from operations of approximately $230 million.
• Preliminary Q2 2025 net loss of approximately $228 million.
• Revised full-year 2025 outlook includes a higher Medical Loss Ratio (86.0% to 87.0%) and a larger Loss from Operations ($300 million to $200 million loss).
• Overall ACA Marketplace risk scores increased by more than prior estimates, indicating higher average morbidity in the market.
• Elevated utilization by members persisted in Q2 2025.

Risks

• Ability to execute strategy and manage growth effectively, including integrating strategic acquisitions.
• Ability to retain and expand member base.
• Ability to accurately estimate incurred medical expenses, including due to changes or inaccuracies in actuarial assumptions, or to effectively manage medical or related administrative costs.
• Ability to maintain profitability in the future.
• Unanticipated results of or changes to risk adjustment programs.
• Ability to arrange for delivery of quality care and maintain good relations with brokers and providers.
• Evolving federal and state laws and regulations, including changes to the Patient Protection and Affordable Care Act (ACA), non-renewal of enhanced APTCs, new program integrity rules, or other government actions.
• Ability to comply with ongoing regulatory requirements, including capital reserve and surplus requirements.
• Changes or developments in the health insurance markets in the United States.
• Ability to comply with laws, regulations, and standards related to handling of information about individuals or consumer protection laws.
• Heightened competition in markets.
• Ability to utilize quota share reinsurance to meet capital and surplus requirements and protect against downside risk.
• Unfavorable or costly outcomes of lawsuits, audits, investigations, and other third-party claims.
• Incurrence of data security breaches.
• Ability to attract and retain qualified personnel.
• Ability to detect and prevent material weaknesses or significant control deficiencies in internal controls.
• Adverse publicity or other adverse consequences related to dual class structure or controlled company status.

Future Outlook

The company anticipates that elevated trends observed in market risk scores and recent company utilization patterns will persist for the remainder of 2025. It plans to resubmit rate filings for 2026 in states covering approximately 98% of current membership to reflect the higher market risk scores in the ACA Marketplace, indicating appropriate pricing actions for the upcoming year.

Management Comments

• "The individual market is a competitive healthcare marketplace that provides affordable, high-quality coverage for millions of consumers across the country."
• "We are taking appropriate pricing actions for 2026 that reflect higher acuity in the individual market, and we will continue to take steps to deliver for our members, partners, and shareholders."
• "Oscar has successfully navigated dynamic markets before and we remain committed to our long-term strategy to bring more employees, individuals, and families healthcare choices that fit their needs through the individual market."

Industry Context

The announcement highlights the dynamic and competitive nature of the individual healthcare market, specifically the ACA Marketplace. The increase in overall ACA Marketplace risk scores suggests a broader trend of higher average morbidity among insured individuals in this segment, impacting all carriers. Oscar's response of adjusting 2026 rates reflects a common industry practice to adapt to changing risk profiles and utilization trends.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to benchmark Oscar Health's performance against industry standards. The discussion focuses on internal estimates and market-wide risk score changes rather than direct competitor comparisons.

Stakeholder Impact

• Shareholders: Negative impact due to revised downward financial guidance, increased losses, and higher MLR, potentially leading to share price decline.
• Members: Potential impact from future pricing actions for 2026, reflecting higher acuity in the individual market.
• Partners: Continued collaboration with providers and brokers is implied, but financial performance could affect future relationships.

Next Steps

• Release second quarter 2025 financial results before market open on Wednesday, August 6, 2025.
• Host a conference call to review results at 8:00 AM (ET) on August 6, 2025.
• Resubmit rate filings for 2026 in states covering approximately 98% of current membership to reflect higher market risk scores.

Key Dates

Recommendation

The significant downward revision of full-year 2025 financial guidance, including a wider projected loss from operations and a higher medical loss ratio, indicates deteriorating financial performance driven by adverse market conditions (higher risk scores, elevated utilization). While management is taking steps for 2026, the immediate outlook is concerning, suggesting a negative impact on profitability and potentially requiring a re-evaluation of the company's valuation. Investors should consider reducing exposure given the increased financial risk and uncertainty.

Keywords

Healthcare technology, Health insurance, ACA Marketplace, Risk adjustment, Medical loss ratio, Financial guidance, Preliminary results, Q2 2025, 2025 outlook, Oscar Health